Literature DB >> 16183645

Knockdown of glutamate-cysteine ligase by small hairpin RNA reveals that both catalytic and modulatory subunits are essential for the survival of primary neurons.

Juan I Diaz-Hernandez1, Angeles Almeida, Maria Delgado-Esteban, Emilio Fernandez, Juan P Bolaños.   

Abstract

Glutathione deficiency is an early biochemical feature that occurs during apoptotic neuronal death associated with certain neurological disorders such as Parkinson disease. However, whether specific targeting of glutathione biosynthesis in neurons is sufficient to trigger neurodegeneration remains undetermined. To address this issue, we used a vector-based small hairpin RNA (shRNA) strategy to knock down each subunit of glutamate-cysteine ligase (GCL; gamma-glutamylcysteine synthetase), the heterodimeric enzyme that catalyzes the rate-limiting step of glutathione biosynthesis. Independent targeting of the catalytic and modulatory subunits by shRNA caused disruption of GCL as assessed by Northern and Western blotting, enzyme activity, and glutathione concentrations. Silencing each subunit in primary cortical neurons spontaneously elicited time-dependent apoptotic death, an effect that was synergistic with glutamate or nitric oxide treatment. Moreover, neuronal apoptosis by GCL knockdown was rescued by expressing the corresponding subunit full-length cDNA carrying silent mutations within the shRNA target cDNA sequence and by incubating neurons with gamma-glutamylcysteine or glutathione ethyl ester. In contrast, supplying glutathione precursors to neurons from co-cultured astrocytes did not prevent the apoptotic death triggered by GCL knockdown. Finally, overexpressing the catalytic (but not modulatory) GCL subunit full-length cDNA increased enzyme activity and glutathione concentrations, yielding neurons more resistant to glutamate- or nitric oxide-mediated apoptosis. Thus, specific and independent disruption of each subunit of GCL in neurons can be said to cause a primary decrease in glutathione that is sufficient to promote neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16183645     DOI: 10.1074/jbc.M507065200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Long-term primary culture of highly-pure rat embryonic hippocampal neurons of low-density.

Authors:  Hao Yang; Rui Cong; Luo Na; Gong Ju; Si-Wei You
Journal:  Neurochem Res       Date:  2010-05-26       Impact factor: 3.996

Review 2.  Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of small-molecule nucleic acid-based gene-silencing strategies.

Authors:  Ravinay Bhindi; Roger G Fahmy; Harry C Lowe; Colin N Chesterman; Crispin R Dass; Murray J Cairns; Edward G Saravolac; Lun-Quan Sun; Levon M Khachigian
Journal:  Am J Pathol       Date:  2007-08-23       Impact factor: 4.307

3.  Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.

Authors:  Antonio Gonzalez
Journal:  Neurochem Res       Date:  2020-01-27       Impact factor: 3.996

4.  Calanquinone A induces anti-glioblastoma activity through glutathione-involved DNA damage and AMPK activation.

Authors:  Fan-Lun Liu; Jui-Ling Hsu; Yean-Jang Lee; Yu-Shun Dong; Fan-Lu Kung; Ching-Shih Chen; Jih-Hwa Guh
Journal:  Eur J Pharmacol       Date:  2014-03-06       Impact factor: 4.432

5.  Intertwined ROS and Metabolic Signaling at the Neuron-Astrocyte Interface.

Authors:  Carlos Vicente-Gutiérrez; Daniel Jiménez-Blasco; Rubén Quintana-Cabrera
Journal:  Neurochem Res       Date:  2020-01-27       Impact factor: 3.996

6.  Post-translational Activation of Glutamate Cysteine Ligase with Dimercaprol: A NOVEL MECHANISM OF INHIBITING NEUROINFLAMMATION IN VITRO.

Authors:  Pallavi B McElroy; Ashwini Sri Hari; Brian J Day; Manisha Patel
Journal:  J Biol Chem       Date:  2017-02-15       Impact factor: 5.157

Review 7.  Glutathione efflux and cell death.

Authors:  Rodrigo Franco; John A Cidlowski
Journal:  Antioxid Redox Signal       Date:  2012-07-16       Impact factor: 8.401

8.  Refocusing the Brain: New Approaches in Neuroprotection Against Ischemic Injury.

Authors:  Cristina Rodriguez; Jesús Agulla; María Delgado-Esteban
Journal:  Neurochem Res       Date:  2020-03-18       Impact factor: 3.996

9.  Manipulation of cellular GSH biosynthetic capacity via TAT-mediated protein transduction of wild-type or a dominant-negative mutant of glutamate cysteine ligase alters cell sensitivity to oxidant-induced cytotoxicity.

Authors:  Donald S Backos; Chad N Brocker; Christopher C Franklin
Journal:  Toxicol Appl Pharmacol       Date:  2009-11-13       Impact factor: 4.219

10.  Overexpression of glutamate-cysteine ligase protects human COV434 granulosa tumour cells against oxidative and gamma-radiation-induced cell death.

Authors:  Mabel M Cortes-Wanstreet; Erich Giedzinski; Charles L Limoli; Ulrike Luderer
Journal:  Mutagenesis       Date:  2009-01-18       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.